The average one-year price target for CalciMedica (NASDAQCM:CALC) has been revised to $38.25 / share, up 400.00% from the prior estimate of $7.65 dated August 25, 2026. These figures represent aggregate analyst targets and do not constitute an investment recommendation by Fintel.